Important clinical factors in sequential therapy including lenvatinib against unresectable hepatocellular carcinoma

Atsushi Hiraoka*, Takashi Kumada, Masanori Atsukawa, Masashi Hirooka, Kunihiko Tsuji, Toru Ishikawa, Koichi Takaguchi, Kazuya Kariyama, Ei Itobayashi, Kazuto Tajiri, Noritomo Shimada, Hiroshi Shibata, Hironori Ochi, Toshifumi Tada, Hidenori Toyoda, Kazuhiro Nouso, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Korenobu HayamaMichitaka Imai, Kouji Joko, Hironori Tanaka, Tsutomu Tamai, Yohei Koizumi, Yoichi Hiasa, Kojiro Michitaka, Masatoshi Kudo

*この論文の責任著者

研究成果: ジャーナルへの寄稿学術論文査読

75 被引用数 (Scopus)

フィンガープリント

「Important clinical factors in sequential therapy including lenvatinib against unresectable hepatocellular carcinoma」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science